Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (8): 704-709.DOI: 10.3969/j.issn.1673-8640.2019.08.007
Previous Articles Next Articles
WANG Jing, ZHENG Qun, JIN Xiaxia, LU Guoguang, SHEN Bo()
Received:
2019-01-04
Online:
2019-08-30
Published:
2019-08-27
CLC Number:
WANG Jing, ZHENG Qun, JIN Xiaxia, LU Guoguang, SHEN Bo. Role of RDW combined determination with NLR in ankylosing spondylitis[J]. Laboratory Medicine, 2019, 34(8): 704-709.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.08.007
组别 | 例数 | 年龄(岁) | 男性[例(%)] | WBC计数(×109/L) | NLR | RBC计数(×1012/L) |
---|---|---|---|---|---|---|
AS组 | 78 | 41(29~52) | 51(65.4) | 6.6(5.5~8.6) | 2.63(1.71~3.55) | 4.24(3.69~4.80) |
健康对照组 | 78 | 40(30~53) | 55(70.5) | 6.0(5.2~7.0) | 1.67(1.38~2.11) | 5.05(4.70~5.34) |
P值 | 0.783 | 0.607 | 0.004 | 0.000 | 0.000 | |
组别 | Hb(g/L) | HCT | MCV(fL) | MCH(pg) | MCHC(g/L) | RDW |
AS组 | 116(101~138) | 0.361(0.313~0.410) | 86.9(83.0~89.9) | 28.8(27.0~29.9) | 327(317~333) | 13.4(12.5~14.3) |
健康对照组 | 150(140~159) | 0.456(0.420~0.479) | 89.0(87.7~90.9) | 29.4(28.6~30.2) | 330(324~332) | 12.5(12.2~12.8) |
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.150 | 0.000 |
组别 | PLT计数(×109/L) | MPV(fL) | ESR(mm/h) | CRP(g/L) | IgG(g/L) | |
AS组 | 260(214~327) | 10.2(9.6~10.7) | 37(20~75) | 32.1(14.1~76.0) | 15.0(11.8~16.3) | |
健康对照组 | 255(220~281) | 9.5(8.5~10.5) | 6(3~9) | 2.85(1.48~4.93) | 12.9(11.4~14.3) | |
P值 | 0.345 | 0.002 | 0.000 | 0.000 | 0.001 | |
组别 | IgA(g/L) | IgM(g/L) | C3(g/L) | C4(g/L) | ASO(kIU/L) | |
AS组 | 3.26(2.53~4.85) | 1.27(1.03~1.92) | 1.13(0.94~1.36) | 0.24(0.19~0.33) | 39.9(25.2~65.5) | |
健康对照组 | 2.32(1.77~2.96) | 1.06(0.83~1.40) | 1.10(0.98~1.28) | 0.26(0.21~0.32) | 49.6(30.4~76.7) | |
P值 | 0.000 | 0.005 | 0.671 | 0.494 | 0.247 |
组别 | 例数 | 年龄(岁) | 男性[例(%)] | WBC计数(×109/L) | NLR | RBC计数(×1012/L) |
---|---|---|---|---|---|---|
AS组 | 78 | 41(29~52) | 51(65.4) | 6.6(5.5~8.6) | 2.63(1.71~3.55) | 4.24(3.69~4.80) |
健康对照组 | 78 | 40(30~53) | 55(70.5) | 6.0(5.2~7.0) | 1.67(1.38~2.11) | 5.05(4.70~5.34) |
P值 | 0.783 | 0.607 | 0.004 | 0.000 | 0.000 | |
组别 | Hb(g/L) | HCT | MCV(fL) | MCH(pg) | MCHC(g/L) | RDW |
AS组 | 116(101~138) | 0.361(0.313~0.410) | 86.9(83.0~89.9) | 28.8(27.0~29.9) | 327(317~333) | 13.4(12.5~14.3) |
健康对照组 | 150(140~159) | 0.456(0.420~0.479) | 89.0(87.7~90.9) | 29.4(28.6~30.2) | 330(324~332) | 12.5(12.2~12.8) |
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.150 | 0.000 |
组别 | PLT计数(×109/L) | MPV(fL) | ESR(mm/h) | CRP(g/L) | IgG(g/L) | |
AS组 | 260(214~327) | 10.2(9.6~10.7) | 37(20~75) | 32.1(14.1~76.0) | 15.0(11.8~16.3) | |
健康对照组 | 255(220~281) | 9.5(8.5~10.5) | 6(3~9) | 2.85(1.48~4.93) | 12.9(11.4~14.3) | |
P值 | 0.345 | 0.002 | 0.000 | 0.000 | 0.001 | |
组别 | IgA(g/L) | IgM(g/L) | C3(g/L) | C4(g/L) | ASO(kIU/L) | |
AS组 | 3.26(2.53~4.85) | 1.27(1.03~1.92) | 1.13(0.94~1.36) | 0.24(0.19~0.33) | 39.9(25.2~65.5) | |
健康对照组 | 2.32(1.77~2.96) | 1.06(0.83~1.40) | 1.10(0.98~1.28) | 0.26(0.21~0.32) | 49.6(30.4~76.7) | |
P值 | 0.000 | 0.005 | 0.671 | 0.494 | 0.247 |
组别 | 例数 | ESR(mm/h) | CRP(g/L) | IgG(g/L) | IgA(g/L) | IgM(g/L) |
---|---|---|---|---|---|---|
RDW≤13.2组 | 33 | 30(16~53) | 22.0(10.7~65.5) | 14.0(10.9~15.6) | 2.81(1.93~4.37) | 1.12(1.01~1.57) |
RDW>13.2组 | 45 | 57(22~84) | 41.6(22.5~79.9) | 15.1(13.3~19.5) | 3.66(2.79~5.01) | 1.46(1.03~2.72) |
P值 | 0.014 | 0.063 | 0.148 | 0.111 | 0.102 | |
组别 | RDW | NLR | 病程(年) | HLA-B27(+) | 总CD3 | |
RDW≤13.2组 | 12.5(12.3~12.8) | 2.13(1.60~3.30) | 7.0(2.0~10.0) | 27(81.8%) | 71.5(67.0~76.0) | |
RDW>13.2组 | 14.0(13.6~15.3) | 2.83(1.94~3.79) | 4.5(0.5~13.8) | 43(95.6%) | 69.5(63.5~77.3) | |
P值 | 0.000 | 0.233 | 0.329 | 0.065 | 0.711 |
组别 | 例数 | ESR(mm/h) | CRP(g/L) | IgG(g/L) | IgA(g/L) | IgM(g/L) |
---|---|---|---|---|---|---|
RDW≤13.2组 | 33 | 30(16~53) | 22.0(10.7~65.5) | 14.0(10.9~15.6) | 2.81(1.93~4.37) | 1.12(1.01~1.57) |
RDW>13.2组 | 45 | 57(22~84) | 41.6(22.5~79.9) | 15.1(13.3~19.5) | 3.66(2.79~5.01) | 1.46(1.03~2.72) |
P值 | 0.014 | 0.063 | 0.148 | 0.111 | 0.102 | |
组别 | RDW | NLR | 病程(年) | HLA-B27(+) | 总CD3 | |
RDW≤13.2组 | 12.5(12.3~12.8) | 2.13(1.60~3.30) | 7.0(2.0~10.0) | 27(81.8%) | 71.5(67.0~76.0) | |
RDW>13.2组 | 14.0(13.6~15.3) | 2.83(1.94~3.79) | 4.5(0.5~13.8) | 43(95.6%) | 69.5(63.5~77.3) | |
P值 | 0.000 | 0.233 | 0.329 | 0.065 | 0.711 |
组别 | 例数 | ESR(mm/h) | CRP(g/L) | IgG(g/L) | IgA(g/L) | IgM(g/L) |
---|---|---|---|---|---|---|
NLR≤2.14组 | 32 | 32(13~73) | 23.4(9.4~57.1) | 14.6(11.4~16.1) | 3.16(2.15~4.82) | 1.39(1.04~2.34) |
NLR>2.14组 | 46 | 53(22~77) | 44.7(21.5~83.1) | 15.1(11.8~19.1) | 3.66(2.77~4.93) | 1.22(1.02~1.90) |
P值 | 0.073 | 0.018 | 0.615 | 0.494 | 0.633 | |
组别 | RDW | NLR | 病程(年) | HLA-B27(+) | 总CD3 | |
NLR≤2.14组 | 13.0(12.4~14.2) | 1.63(1.26~1.90) | 5.0(1.5~10.0) | 30(93.8%) | 72.0(68.0~79.0) | |
NLR>2.14组 | 13.4(12.7~14.3) | 3.33(2.83~5.01) | 7.0(1.0~15.0) | 40(87.0%) | 70.0(63.0~76.0) | |
P值 | 0.224 | 0.000 | 0.735 | 0.460 | 0.280 |
组别 | 例数 | ESR(mm/h) | CRP(g/L) | IgG(g/L) | IgA(g/L) | IgM(g/L) |
---|---|---|---|---|---|---|
NLR≤2.14组 | 32 | 32(13~73) | 23.4(9.4~57.1) | 14.6(11.4~16.1) | 3.16(2.15~4.82) | 1.39(1.04~2.34) |
NLR>2.14组 | 46 | 53(22~77) | 44.7(21.5~83.1) | 15.1(11.8~19.1) | 3.66(2.77~4.93) | 1.22(1.02~1.90) |
P值 | 0.073 | 0.018 | 0.615 | 0.494 | 0.633 | |
组别 | RDW | NLR | 病程(年) | HLA-B27(+) | 总CD3 | |
NLR≤2.14组 | 13.0(12.4~14.2) | 1.63(1.26~1.90) | 5.0(1.5~10.0) | 30(93.8%) | 72.0(68.0~79.0) | |
NLR>2.14组 | 13.4(12.7~14.3) | 3.33(2.83~5.01) | 7.0(1.0~15.0) | 40(87.0%) | 70.0(63.0~76.0) | |
P值 | 0.224 | 0.000 | 0.735 | 0.460 | 0.280 |
[1] | 肖林林,王璐璐,赵卫卫,等. ROC曲线在HLA-B27界值设置中的应用[J]. 检验医学, 2016,31(4):338-339. |
[2] | BRAUN J,SIEPER J.Ankylosing spondylitis[J]. Lancet,2007,369(9570):1379-1390. |
[3] | SMITH J A.Update on ankylosing spondylitis:current concepts in pathogenesis[J]. Curr Allergy Asthma Rep,2015,15(1):489. |
[4] | RABELO C F, BAPTISTA T S A,PETERSEN L E,et al. Serum IL-6 correlates with axial mobility index(bath ankylosing spondylitis metrology index) in Brazilian patients with ankylosing spondylitis[J]. Open Access Rheumatol,2018,10:21-25. |
[5] | LIPPI G,TARGHER G,MONTAGNANA M,et al.Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients[J]. Arch Pathol Lab Med,2009,133(4):628-632. |
[6] | SEZGIN M,TECER D, KANIK A,et al.Serum RDW and MPV in ankylosing spondylitis:can they show the disease activity?[J]. Clin Hemorheol Microcirc,2017,65(1):1-10. |
[7] | KHAN A A,AKRITIDIS G,PRING T,et al.The neutrophil-to-lymphocyte ratio as a marker of lymph node status in patients with rectal cancer[J]. Oncology,2016,91(2):69-77. |
[8] | LAOHAWIRIYAKAMOL S,MAHATTANOBON S,LAOHAWIRIYAKAMOL S,et al.The pre-treatment neutrophil-lymphocyte ratio:a useful tool in predicting non-sentinel lymph node metastasis in breast cancer cases[J]. Asian Pac J Cancer Prev ,2017,18(2):557-562. |
[9] | DELGADO-GARCÍA G,GALARZA-DELAGADO D,COLUNGA-PEDRAZA I,et al. Neutrophil-lymphocyte ratio is not superior to lymphocyte count alone in differentiating disease activity in SLE[J]. Ann Rheum Dis,2015,74(Suppl 2):1091-1092. |
[10] | 中华医学会风湿病学分会. 强直性脊柱炎诊断及治疗指南[J]. 中华风湿病学杂志, 2010,14(8):557-559. |
[11] | 李琳芸,彭长华,梅冰,等. 中国人群强直性脊柱炎与ERAP-1基因多态性的相关性Meta分析[J]. 检验医学,2018,33(6):481-485. |
[12] | MAHMOUDI M,ASLANI S,NICKNAM M H,et al.New insights toward the pathogenesis of ankylosing spondylitis;genetic variations and epigenetic modifications[J]. Mod Rheumatol,2016,27(2):198-209. |
[13] | LINDSTRÖM U,EXARCHOU S,LIE E,et al. Infections of the gut,urogenital and respiratory tract and appendicitis during childhood,and the risk of developing ankylosing spondylitis[J]. Ann Rheum Dis,2016,75(Suppl 2):85-86. |
[14] | SCHNEEBERGER E E,ZAMORA N,CITERA G.SASDAS(simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis[J]. Clin Rheumatol,2016,35(11):2865-2866. |
[15] | CHEN C H,CHEN H A,LIAO H T,et al.The clinical usefulness of ESR,CRP,and disease duration in ankylosing spondylitis:the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility[J]. Rheumatol Int,2015,35(7):1263-1267. |
[16] | BRAUN J,BERG V D,BARALIAK O S,et al.2010 Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis[J]. Ann Rheum Dis,2011,70:896-904. |
[17] | 李云春,钟利,王悦,等. 类风湿性关节炎患者红细胞体积分布宽度及相关炎性因子与病情活动度的相关性[J]. 检验医学,2017,32(4):304-307. |
[18] | GORIAL F I,HASSAN A M.Diagnostic performance of red cell distribution width in adult Iraqi patients with ankylosing spondylitis[J]. Arthritis,2018,2018:2904694. |
[19] | BOZAN N,ALPAYCI M,ASLAN M,et al.Mean platelet volume,red cell distribution width,platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds[J]. Eur Arch Otorhinolaryngol,2016,273(11):3663-3672. |
[20] | KUCUK A,USLU A U,UGAN Y,et al.Neutrophil-to-lymphocyte ratio is involved in the severity of ankylosing spondylitis[J]. Bratisl Lek Listy,2015,116(12):722-725. |
[21] | JAMALYARIA F,WARD M M,ASSASSI S,et al.Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups[J]. Clin Rheumatol,2017,36(10):2359-2364. |
[22] | MERCAN R,BITIK B,TUFAN A,et al.The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis[J]. J Clin Lab Anal,2016,30(5):597-601. |
[23] | TAN S,YAO J,FLYNN J A, et al.Quantitative syndesmophyte measurement in ankylosing spondylitis using CT:longitudinal validity and sensitivity to change over 2 years[J]. Ann Rheum Dis,2015,74:437-443. |
[1] | LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure:a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864. |
[2] | DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674. |
[3] | GUO Jie, LI Haixia, LI Xiaoyun. Correlation of preoperative RPR in peripheral blood with the prognosis of endometrial carcinoma patients [J]. Laboratory Medicine, 2023, 38(7): 675-679. |
[4] | WU Caorong, CUI Wen, TANG Binbin, HE Jingjing, LAI Zhikun. Correlations between the ratio of C-reactive protein to prealbumin and the prognosis of patients with acute heart failure [J]. Laboratory Medicine, 2023, 38(6): 579-583. |
[5] | DUAN Yong, WANG Yong, ZHANG Yumin, ZENG Haitao, LIU Qing. Predictive value of red blood cell distribution width for in-hospital mortality in ICU patients with heart failure:a retrospective study based on the MIMIC-Ⅲ database [J]. Laboratory Medicine, 2023, 38(10): 951-956. |
[6] | LI Dongxiu, HUANG Jian. Roles of serum sICAM-1 and hs-CRP levels in monitoring acute viral lower respiratory tract infection in children [J]. Laboratory Medicine, 2022, 37(3): 226-229. |
[7] | SONG Yunxiao, TONG Wei, ZHANG Haichen, ZHANG Yinwang, BIAN Xiaobo, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun, GE Wen, YAO Tianyue. Correlation of systemic inflammatory markers and fracture occurrence in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(3): 235-239. |
[8] | YAO Hualong. Roles of PTH,CRP,OPG/PYR ratio in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(12): 1146-1150. |
[9] | MA Jianguo, ZHU Xiaolin, DING Yongguang, YIN Meng, LI Hongchun. Predictive values of red blood cell distribution width and myocardial markers for acute myocardial infarction in patients with CAS [J]. Laboratory Medicine, 2022, 37(12): 1164-1168. |
[10] | HE Yaya, CHEN Shanshan, LI Yongsheng, LIU Juan. Expressions of sLAIR-1 and LAIR-1 mRNA in AS patients and their relationship with disease activity [J]. Laboratory Medicine, 2022, 37(10): 915-920. |
[11] | HE Xuelian, HE Ziyi, LIU Yueyang, YU Yanzhi, ZHANG Siying. Role of line chart model based on peripheral blood-derived inflammation markers in early diagnosis of neonatal septicemia [J]. Laboratory Medicine, 2022, 37(10): 921-927. |
[12] | LIU Chunxiao, YI Changlin, WANG Xiaoshan, ZHU Yongzhen, LUO Aner, CHEN Changqiang. Roles of MxA,CRP and WBC count in the differential diagnosis of acute respiratory tract viral and bacterial infections [J]. Laboratory Medicine, 2022, 37(10): 944-947. |
[13] | XIONG Zhongbo, WANG Lei, YIN Beiqi, DAI Yue, WEI Xiaoqing, LU Pei. Clinical roles of SAA and CRP in pathological staging and metastasis of gastrointestinal cancer [J]. Laboratory Medicine, 2022, 37(1): 51-55. |
[14] | WANG Qian, ZHU Shiyao, LU Di, ZHU Kun, WU Jiong, QUAN Jiali. Arteriosclerotic cardiovascular disease risk markers research progress [J]. Laboratory Medicine, 2021, 36(4): 447-452. |
[15] | WANG Kehui, HUANG Yun, ZHANG Zhengyin, WANG Yating, XUE Yuqin, CAI Sufang, FAN Chao, JIN Ying, ZHENG Yijing, CHANG Jinfeng. Clinical diagnostic value of serum allergen,IL-6 and CRP levels in patients with acute urticaria [J]. Laboratory Medicine, 2021, 36(3): 300-303. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||